CY1124087T1 - Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων - Google Patents
Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασωνInfo
- Publication number
- CY1124087T1 CY1124087T1 CY20211100437T CY211100437T CY1124087T1 CY 1124087 T1 CY1124087 T1 CY 1124087T1 CY 20211100437 T CY20211100437 T CY 20211100437T CY 211100437 T CY211100437 T CY 211100437T CY 1124087 T1 CY1124087 T1 CY 1124087T1
- Authority
- CY
- Cyprus
- Prior art keywords
- protein kinase
- kinase inhibitors
- pyridoquinazoline
- derivatives useful
- ameliorated
- Prior art date
Links
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title abstract 2
- 239000003909 protein kinase inhibitor Substances 0.000 title abstract 2
- NFRCNZHWCNHERP-UHFFFAOYSA-N pyrido[2,3-h]quinazoline Chemical class N1=CN=C2C3=CC=CN=C3C=CC2=C1 NFRCNZHWCNHERP-UHFFFAOYSA-N 0.000 title 1
- BTWJITCWBALZPU-UHFFFAOYSA-N 11-oxopyrido[2,1-b]quinazoline-6-carboxamide Chemical class C1=CC=C2C(=O)N3C=CC=C(C(=O)N)C3=NC2=C1 BTWJITCWBALZPU-UHFFFAOYSA-N 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/082—Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/087—Arrangement or mounting of control or safety devices of electric circuits regulating heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201730759 | 2017-06-01 | ||
| PCT/ES2018/070396 WO2018220252A1 (es) | 2017-06-01 | 2018-05-31 | Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124087T1 true CY1124087T1 (el) | 2022-05-27 |
Family
ID=61569288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100437T CY1124087T1 (el) | 2017-06-01 | 2021-05-20 | Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11021479B2 (OSRAM) |
| EP (1) | EP3632912B1 (OSRAM) |
| JP (1) | JP7110335B2 (OSRAM) |
| KR (1) | KR102629854B1 (OSRAM) |
| CN (1) | CN111247143B (OSRAM) |
| AU (1) | AU2018278283B2 (OSRAM) |
| CA (1) | CA3066009A1 (OSRAM) |
| CY (1) | CY1124087T1 (OSRAM) |
| DK (1) | DK3632912T3 (OSRAM) |
| EA (1) | EA037384B1 (OSRAM) |
| ES (1) | ES2881960T3 (OSRAM) |
| HR (1) | HRP20210814T1 (OSRAM) |
| HU (1) | HUE054792T2 (OSRAM) |
| LT (1) | LT3632912T (OSRAM) |
| MX (1) | MX385475B (OSRAM) |
| PL (1) | PL3632912T3 (OSRAM) |
| PT (1) | PT3632912T (OSRAM) |
| RS (1) | RS61833B1 (OSRAM) |
| SI (1) | SI3632912T1 (OSRAM) |
| SM (1) | SMT202100312T1 (OSRAM) |
| WO (1) | WO2018220252A1 (OSRAM) |
| ZA (1) | ZA201908372B (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7525609B2 (ja) | 2020-01-31 | 2024-07-30 | エルジー エナジー ソリューション リミテッド | 多層構造の無機物層を含む分離膜一体型電極の製造方法及びそれによる分離膜一体型電極 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4551460A (en) | 1982-05-10 | 1985-11-05 | Hoffmann-La Roche Inc. | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis |
| EP0944628B1 (en) | 1996-11-26 | 2002-06-05 | American Cyanamid Company | Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| US7750160B2 (en) | 2003-11-13 | 2010-07-06 | Ambit Biosciences Corporation | Isoxazolyl urea derivatives as kinase modulators |
| US8642660B2 (en) * | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| AU2009320683B2 (en) | 2008-11-28 | 2012-07-19 | Kowa Company, Ltd. | Pyridine-3-carboxyamide derivative |
| ES2833459T3 (es) * | 2014-03-20 | 2021-06-15 | Univ Johns Hopkins | Compuestos que inhiben la ARN polimerasa, composiciones que incluyen dichos compuestos y su uso |
-
2018
- 2018-05-31 EP EP18759146.6A patent/EP3632912B1/en active Active
- 2018-05-31 LT LTEP18759146.6T patent/LT3632912T/lt unknown
- 2018-05-31 CA CA3066009A patent/CA3066009A1/en active Pending
- 2018-05-31 JP JP2020516962A patent/JP7110335B2/ja active Active
- 2018-05-31 CN CN201880048531.4A patent/CN111247143B/zh active Active
- 2018-05-31 US US16/615,867 patent/US11021479B2/en active Active
- 2018-05-31 WO PCT/ES2018/070396 patent/WO2018220252A1/es not_active Ceased
- 2018-05-31 MX MX2019014436A patent/MX385475B/es unknown
- 2018-05-31 SM SM20210312T patent/SMT202100312T1/it unknown
- 2018-05-31 PL PL18759146T patent/PL3632912T3/pl unknown
- 2018-05-31 DK DK18759146.6T patent/DK3632912T3/da active
- 2018-05-31 AU AU2018278283A patent/AU2018278283B2/en active Active
- 2018-05-31 PT PT187591466T patent/PT3632912T/pt unknown
- 2018-05-31 SI SI201830289T patent/SI3632912T1/sl unknown
- 2018-05-31 KR KR1020197038842A patent/KR102629854B1/ko active Active
- 2018-05-31 EA EA201992793A patent/EA037384B1/ru unknown
- 2018-05-31 HU HUE18759146A patent/HUE054792T2/hu unknown
- 2018-05-31 ES ES18759146T patent/ES2881960T3/es active Active
- 2018-05-31 HR HRP20210814TT patent/HRP20210814T1/hr unknown
- 2018-05-31 RS RS20210545A patent/RS61833B1/sr unknown
-
2019
- 2019-12-13 ZA ZA2019/08372A patent/ZA201908372B/en unknown
-
2021
- 2021-05-20 CY CY20211100437T patent/CY1124087T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS61833B1 (sr) | 2021-06-30 |
| PL3632912T3 (pl) | 2021-09-06 |
| KR20200011990A (ko) | 2020-02-04 |
| SI3632912T1 (sl) | 2021-08-31 |
| EP3632912A1 (en) | 2020-04-08 |
| AU2018278283B2 (en) | 2021-06-17 |
| LT3632912T (lt) | 2021-06-10 |
| CN111247143A (zh) | 2020-06-05 |
| AU2018278283A1 (en) | 2019-12-19 |
| ES2881960T3 (es) | 2021-11-30 |
| HRP20210814T1 (hr) | 2021-06-25 |
| JP7110335B2 (ja) | 2022-08-01 |
| BR112019024892A2 (pt) | 2020-06-16 |
| CN111247143B (zh) | 2022-07-05 |
| SMT202100312T1 (it) | 2021-07-12 |
| US20200148676A1 (en) | 2020-05-14 |
| CA3066009A1 (en) | 2018-12-06 |
| DK3632912T3 (da) | 2021-05-10 |
| US11021479B2 (en) | 2021-06-01 |
| JP2020521817A (ja) | 2020-07-27 |
| HUE054792T2 (hu) | 2021-09-28 |
| MX385475B (es) | 2025-03-18 |
| EA201992793A1 (ru) | 2020-03-26 |
| MX2019014436A (es) | 2020-02-10 |
| ZA201908372B (en) | 2021-04-28 |
| PT3632912T (pt) | 2021-06-02 |
| EP3632912B1 (en) | 2021-03-17 |
| KR102629854B1 (ko) | 2024-01-25 |
| WO2018220252A1 (es) | 2018-12-06 |
| EA037384B1 (ru) | 2021-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021005987A2 (es) | Compuestos de anillo fusionado | |
| CY1123595T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 | |
| CL2021000387A1 (es) | Compuestos de anillo fusionado | |
| CY1122046T1 (el) | Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων | |
| BR112018005497A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| EA201892838A1 (ru) | Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
| EA202190588A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| SA521422152B1 (ar) | Vanin مركبات عطرية غير متجانسة كمثبطات | |
| EA202090014A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| CL2020001020A1 (es) | Derivados de bencimidazol y sus usos. | |
| CY1123722T1 (el) | Ενεσιμα φαρμακευτικα σκευασματα λεφαμουλινης | |
| CY1122077T1 (el) | Νεα δακτυλιωμενα φαινοξυακεταμιδια | |
| EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| CY1123880T1 (el) | Καινοτομοι 5-ητ2 ανταγωνιστες | |
| CY1122381T1 (el) | Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta | |
| EA201991355A1 (ru) | Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта | |
| CY1123185T1 (el) | Παραγωγα ινδολιου | |
| EA202191477A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA202191378A1 (ru) | Активные сложноэфирные производные тестостерона, их композиции и применения | |
| CY1124087T1 (el) | Παραγωγα πυριδοκιναζολινης χρησιμα ως αναστολεις πρωτεϊνικων κινασων | |
| EA202092446A1 (ru) | ТИАЗОЛ- ИЛИ ТИАДИАЗОЛЗАМЕЩЕННЫЕ АРИЛЬНЫЕ И ГЕТЕРОАРИЛЬНЫЕ ПРОИЗВОДНЫЕ КАК ИНГИБИТОРЫ Vps34 | |
| EA201600411A1 (ru) | Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний |